The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it says that we can begin to reduce complications and the work that we do is incredibly important for this patient population in some ways it makes the field of modern type 1 diabetes care because it says there really is something you can do other than holding hold somebody's hand and look for complications
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's a paper that's only known that's in the New England Journal of Medicine it's amazing wonderful paper and it changes type 1 diabetes forever because it says that we can begin to reduce complications
so we should first just talk about the DCCT which is the so-called diabetes control complication trial